000 01097 a2200349 4500
005 20250511182152.0
264 0 _c19921001
008 199210s 0 0 eng d
022 _a0048-5764
040 _aNLM
_beng
_cNLM
100 1 _aBorison, R L
245 0 0 _aRisperidone: clinical safety and efficacy in schizophrenia.
_h[electronic resource]
260 _bPsychopharmacology bulletin
_c1992
300 _a213-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsoxazoles
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPiperidines
_xadverse effects
650 0 4 _aRisperidone
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSchizophrenic Psychology
700 1 _aPathiraja, A P
700 1 _aDiamond, B I
700 1 _aMeibach, R C
773 0 _tPsychopharmacology bulletin
_gvol. 28
_gno. 2
_gp. 213-8
999 _c1387595
_d1387595